Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Soleimani-Meigooni

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2023
Tau PET Visual Reads: Research and Clinical Applications and Future DirectionsDavid N Soleimani-Meigooni, Gil D Rabinovici
Pediatric Dentistry|April 29, 2022
Pharmacokinetics of 38 Percent Silver Diamine Fluoride in ChildrenHellene Ellenikiotis, Kuan-Fu Chen, David N Soleimani-Meigooni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2025
Imaging Synaptic Density in Aging and Alzheimer Disease with [<sup>18</sup>F]SynVesT-1Joseph Giorgio, David N Soleimani-Meigooni, Mustafa Janabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsFleur H C van der Linden, Kaitlin B Casaletto, Argentina Lario Lago, et al.
Journal of Neurovirology|July 17, 2016
JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7David N Soleimani-Meigooni, Katherine E Schwetye, Maria Reyes Angeles, et al.
Neurology. Clinical Practice|June 30, 2025
Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer DiseaseNicholas U Schwartz, Connor D Dietz, Igor Prufer Araújo, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2026
Identification of patients receiving amyloid-targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADSRenaud La Joie, Ganna Blazhenets, Piyush Maiti, et al.
Brain : a Journal of Neurology|August 10, 2021
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's diseaseAmelia Strom, Leonardo Iaccarino, Lauren Edwards, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple CohortsJoseph Giorgio, Ganna Blazhenets, Susan M Landau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumShaney Flores, Thomas Hunter Smith, Jalen Scott, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2023
Tau PET Visual Reads: Research and Clinical Applications and Future DirectionsDavid N Soleimani-Meigooni, Gil D Rabinovici
Pediatric Dentistry|April 29, 2022
Pharmacokinetics of 38 Percent Silver Diamine Fluoride in ChildrenHellene Ellenikiotis, Kuan-Fu Chen, David N Soleimani-Meigooni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2025
Imaging Synaptic Density in Aging and Alzheimer Disease with [<sup>18</sup>F]SynVesT-1Joseph Giorgio, David N Soleimani-Meigooni, Mustafa Janabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsFleur H C van der Linden, Kaitlin B Casaletto, Argentina Lario Lago, et al.
Journal of Neurovirology|July 17, 2016
JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7David N Soleimani-Meigooni, Katherine E Schwetye, Maria Reyes Angeles, et al.
Neurology. Clinical Practice|June 30, 2025
Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer DiseaseNicholas U Schwartz, Connor D Dietz, Igor Prufer Araújo, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2026
Identification of patients receiving amyloid-targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADSRenaud La Joie, Ganna Blazhenets, Piyush Maiti, et al.
Brain : a Journal of Neurology|August 10, 2021
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's diseaseAmelia Strom, Leonardo Iaccarino, Lauren Edwards, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple CohortsJoseph Giorgio, Ganna Blazhenets, Susan M Landau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumShaney Flores, Thomas Hunter Smith, Jalen Scott, et al.
Pageof 7